CVS Health Reports Strong Q2 2025 Results, Updates Full-Year Guidance
CVS Health Corporation reported a significant increase in revenue for Q2 2025, surpassing expectations.
BTC$62,686.00-1.67%
ETH$1,666.62-3.16%
USDT$0.9987-0.01%
USDC$0.9996-0.01%
XRP$1.10-1.88%
SOL$69.40-3.23%
TRX$0.329-1.01%
FIGR_HELOC$1.03-0.16%
HYPE$61.30-7.24%
DOGE$0.0789-3.56%
USDS$0.9997+0.00%
RAIN$0.0157-2.06%
LEO$9.49-0.84%
ZEC$413.84-6.89%
XLM$0.1911-3.05%
BTC$62,686.00-1.67%
ETH$1,666.62-3.16%
USDT$0.9987-0.01%
USDC$0.9996-0.01%
XRP$1.10-1.88%
SOL$69.40-3.23%
TRX$0.329-1.01%
FIGR_HELOC$1.03-0.16%
HYPE$61.30-7.24%
DOGE$0.0789-3.56%
USDS$0.9997+0.00%
RAIN$0.0157-2.06%
LEO$9.49-0.84%
ZEC$413.84-6.89%
XLM$0.1911-3.05%
CVS Health reported Q3 2025 revenue of $102.9 billion and adjusted EPS of $1.60, topping expectations.
CVS Health Corporation reported a significant increase in revenue for Q2 2025, surpassing expectations.
CVS Health Corporation reported strong financial results for the first quarter of 2025, with revenues and earnings surpassing expectations.
In the fourth quarter of fiscal year 2024, CVS Health Corporation reported a 4.2% increase in total revenues, reaching $97.7 billion.
CVS Health Corporation (NYSE: CVS) reported a 6.3% increase in total revenues for the third quarter of 2024, reaching $95.4 billion.
Hedge fund Glenview Capital plans to meet with CVS Health executives to propose operational changes amid the company's struggling stock performance and financial challenges.
CVS Health Corporation (NYSE: CVS) reported a 3.7% increase in total revenues for the first quarter of 2024, reaching $88.4 billion, driven by Health Care Benefits…
CVS Health Corp. reported a successful Q4 2023, achieving $93.8 billion in revenue.
These 6 dividend stocks show good signs going into the future — which isn't exactly commonplace right now.